Биология ва тиббиёт муаммолари 2025, №4 (163)
Subject of the article
БИР ФОТОНЛИ ЭМИССИОН КОМПЮТЕР ТОМОГРАФИЯНИ ҚАЛҚОНСИМОН БЕЗ ФОЛЛИКУЛЯР САРАТОНИ ТАШХИСОТИДАГИ ЎРНИ (145-152)
Authors
Нурмухамедов Дониёрбек Бахтиёрович, Хайдарова Феруза Алимовна
Institution
Академик Ё.Х.Турақулов номидаги Республика ихтисослаштирилган эндокринология илмий-амалий тиббиёт маркази, Ўзбекистон Республикаси, Тошкент ш.
Abstract
Қалқонсимон без фолликуляр саратонини аниқлаш муаммоси ҳозирги тиббий амалиётда катта аҳамият касб этмоқда, чунки у клиник ва цитологик жиҳатдан аденомаларга жуда ўхшаш бўлиб, кўп ҳолларда фақат гистологик текширувларда тасдиқланади. Радионуклидли диагностика, хусусан, бир фотонли эмиссион компютер томографияси (БФЭКТ/КT), фолликуляр саратонларни эрта ва аниқ ташхис қилишда истиқболли усул сифатида кўриб чиқилмоқда. У метаболик фаолликни баҳолаш, функцияси бузилган тўқималарни аниқлаш ва ҳудудий тарқалиш ҳолатини баҳолаш имконини беради. Мазкур тадқиқотда академик Ё.Х. Турақулов номидаги РИЭИАТМ клиникасида 2021–2022 йиллар мобайнида таҳлил қилинган беморлар маълумотлари асосида БФЭКТ/КT усулининг қалқонсимон без фолликуляр саратонини ташхис қилишдаги самарадорлиги баҳоланди. Ушбу усулнинг ултратовуш текшируви (УТТ), ингичка игнали аспирацион биопсия (ИИАБ) ва гистология билан таққосланган ҳолда сезгирлиги, аниқлиги ва клиник қиймати таҳлил қилинди.
Key words
фолликуляр қалқонсимон без саратони, бир фотонли эмиссион компютер томографияси (БФЭКТ/КT), радионуклид диагностика, тугунли бўқоқ, гистологик хулоса, УТТ, ИИАБ.
Literature
1. Pelizzo MR, Piotto A, Bernante P, Boschin IM, Toniato A, Pagetta C, Rubello D, Busnardo B. Differentiated thyroid cancer: therapeutic approaches and prognostic factors. Cancer. 2004;100(5):896–900/DOI: 10.1002/cncr.20081 2. Ito Y, Miyauchi A. Prognostic factors and therapeutic strategies of thyroid carcinoma. World J Endoc Surg. 2010;2(1):1–7/DOI: 10.5005/jp-journals-10002-1023 3. Baloch ZW, LiVolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol. 2002;117(1):143–150/DOI: 10.1309/8VL9-ECXY-NVMX-2RQF 4. Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 2012;56(4):333–339/DOI: 10.1159/000337291 5. Oh JR, Song HC, Chong A, Min JJ, Kim J, Jeong SY, Lee DS, Chung JK. Additional value of single-photon emission computed tomography/computed tomography (SPECT/CT) in the diagnosis of recurrent thyroid cancer. Ann Nucl Med. 2012;26(7):551–557/DOI: 10.1007/s12149-012-0611-3 6. Chung JK. The role of nuclear medicine in thyroid cancer: a Korean perspective. Nucl Med Mol Imaging. 2010;44(4):220–228/DOI: 10.1007/s13139-010-0044-y 7. Sisson JC, Freitas JE, McDougall IR, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association/Thyroid. 2011;21(4):335–346/DOI: 10.1089/thy.2010.0403 8. Zilioli V, Peli A, Panarotto MB, et al. Differentiated thyroid carcinoma: Incremental diagnostic value of 131I SPECT/CT over planar whole body scan after radioiodine therapy/Endocrine. 2017;56(3):551–559/DOI: 10.1007/s12020-016-1086-3 9. Cibas, E. S., & Ali, S. Z. (2017). The Bethesda System for Reporting Thyroid Cytopathology. Thyroid, 27(11), 1341–1346. https://doi.org/10.1089/thy.2017.0500 10. Trimboli, P., Treglia, G., Guidobaldi, L., et al. (2015). The Use of Cytology and Ultrasound in the Management of Thyroid Nodules. Endocrine, 49(3), 709–713. https://doi.org/10.1007/s12020-015-0542-0 11. Trimboli, P., Castellana, M., Piccardo, A., et al. (2021). Evidence-based appraisal on hybrid SPECT/CT for thyroid cancer: a systematic review. Endocrine, 72(1), 1–9. https://doi.org/10.1007/s12020-021-02682-5 12. Jhiang, S. M., Liu, M., & Wu, S. Y. (2019). Radioiodine uptake and differentiation of thyroid cancer cells. Endocrine-Related Cancer, 26(3), R153–R164. https://doi.org/10.1530/ERC-18-0441 13. Chen, L., Luo, Q., Shen, Y., et al. (2016). Diagnostic value of SPECT/CT in patients with thyroid nodules: a meta-analysis. Clinical Nuclear Medicine, 41(3), 201–207. https://doi.org/10.1097/RLU.0000000000001072 14. Tessler, F. N., Middleton, W. D., Grant, E. G., et al. (2017). ACR TI-RADS: an ultrasound reporting system for thyroid nodules. Radiology, 287(1), 29–36. https://doi.org/10.1148/radiol.2017161659 15. Haugen, B. R., Alexander, E. K., Bible, K. C., et al. (2016). 2015 ATA Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26(1), 1–133. https://doi.org/10.1089/thy.2015.0020 16. Bongiovanni, M., Spitale, A., Faquin, W. C., et al. (2012). The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytologica, 56(4), 333–339. https://doi.org/10.1159/000337291 17. Sharma, N., & Dey, P. (2018). Thyroid FNAC: A cyto-histological correlation and review of the literature. Diagnostic Cytopathology, 46(5), 394–401. https://doi.org/10.1002/dc.23896 18. Gross, M. D. (2002). Imaging of thyroid nodules and differential diagnosis. Endocrinology and Metabolism Clinics, 31(3), 501–520.